Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000075.xml
Semin Respir Crit Care Med 2004; 25(1): 53-61
DOI: 10.1055/s-2004-822305
DOI: 10.1055/s-2004-822305
Immunity Against Mycobacteria
Carol M. Mason1 , Juzar Ali1Further Information
Publication History
Publication Date:
12 March 2004 (online)
Mycobacterium tuberculosis is the most prevalent infectious pathogen in the world, largely due to its unique interactions with the human immune system. Even in a normal host, a frequent outcome of infection with M. tuberculosis is failure to completely eradicate the organisms, despite the development of cell-mediated immunity. Viable organisms persist in a state in which they do not progressively replicate, leading to latent infection, which carries a risk of breakdown into active (reactivation) tuberculosis at some point later in life. Key features of the immune response against mycobacteria are reviewed here, and potential mechanisms by which the organisms may subvert these host defenses are discussed. Despite the multicellular nature of the host response to infecting mycobacteria, the organisms cannot be eradicated and contribute to the ongoing worldwide epidemic with tuberculosis.
KEYWORDS
Mycobacteria - immunity - cytokines - granuloma
REFERENCES
- 1 World Health Organization .Groups at risk: report on the tuberculosis epidemic. Geneva; WHO 1996
- 2 Raviglione M, Snider Jr D, Kochi A. Global epidemiology of tuberculosis: morbidity and mortality of a worldwide epidemic. JAMA. 1995; 273 220-226
- 3 Sahn S, Neff T. Miliary tuberculosis. Am J Med. 1974; 56 495-505
- 4 Barnes P, Bloch A, Davidson P, Snider D. Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med. 1991; 324 1644-1650
- 5 Cohn D, O'Brien R, Geiter L et al.. American Thoracic Society/Centers for Disease Control and Prevention: targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med. 2000; 161 S221-S247
- 6 Reiling N, Holscher C, Fehrenbach A et al.. Cutting edge: toll-like receptor (TLR)2- and TLR4-mediated pathogen recognition in resistance in airborne infection with Mycobacterium tuberculosis . J Immunol. 2002; 169 3480-3484
- 7 Schlesinger L. Role of mononuclear phagocytes in M. tuberculosis pathogenesis. J Investig Med. 1996; 44 312-323
- 8 Sturgill-Koszcki S, Schlesinger P, Chakraborty P et al.. Lack of acidification in mycobacterium phagosomes produced by exclusion of the vesicular proton-ATPase. Science. 1994; 263 678-681
- 9 Malik Z, Thompson C, Hashimi S, Porter B, Iyer S, Kusner D. Cutting edge: Mycobacterium tuberculosis blocks Ca2+ signaling and phagosome maturation in human macrophages via specific inhibition of sphingosine kinase. J Immunol. 2003; 170 2811-2815
- 10 Russell D. Mycobacterium tuberculosis: here today and here tomorrow. Nature Reviews. 2001; 2 1-9
- 11 Brown D, Miles B, Zwilling B. Growth of Mycobacterium tuberculosis in BCG-resistant and -susceptible mice: establishment of latency and reactivation. Infect Immun. 1995; 63 2243-2247
- 12 Bellamy R, Ruwende C, Corrah T, McAdam K, Whittle H, Hill A. Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans. N Engl J Med. 1998; 338 640-644
- 13 Schaible U, Sturgill-Koszycki S, Schlesinger P, Russell D. Cytokine activation leads to acidification and increases maturation of Mycobacterium avium-containing phagosomes in murine macrophages. J Immunol. 1998; 160 1290-1296
- 14 Denis M. Interferon-gamma-treated macrophages inhibit growth of tubercle bacilli via the generation of reactive nitrogen intermediates. Cell Immunol. 1991; 132 150-157
- 15 Flesch I, Kaufmann S. Mechanisms involved in mycobacterial growth inhibition by gamma interferon-activated bone marrow macrophages: role of reactive nitrogen intermediates. Infect Immun. 1991; 59 3213-3218
- 16 Wang J, Wakeham J, Harkness R, Xing Z. Macrophages are a significant source of type 1 cytokines during mycobacterial infection. J Clin Invest. 1999; 103 1023-1029
- 17 Park A, Hondowicz B, Kopf M, Scott P. The role of IL-12 in maintaining resistance to Leishmania major . J Immunol. 2002; 168 5771-5777
- 18 Fulton S, Johnsen J, Wolf S, Sieburth D, Boom W. Interleukin-12 production by human monocytes infected with Mycobacterium tuberculosis: role of phagocytosis. Infect Immun. 1996; 64 2523-2531
- 19 Flesch I, Hess J, Huang S et al.. Early interleukin 12 production by macrophages in response to mycobacteial infection depends on interferon-γ and tumor necrosis factor-α. J Exp Med. 1995; 181 1615-1621
- 20 Flynn J, Goldstein M, Triebold K, Sypek J, Wolf S, Bloom B. IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection. J Immunol. 1995; 155 2515-2524
- 21 Cooper A, Magram J, Ferrante J, Orme I. Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis . J Exp Med. 1997; 186 39-45
- 22 Cooper A, Kipnis A, Turner J, Magram J, Ferrante J, Orme I. Mice lacking bioactive IL-12 can generate protective antigen-specific cellular responses to mycobacterial infection only if the IL-12 p40 subunit is present. J Immunol. 2002; 168 1322-1327
- 23 Yamada H, Mizumo S, Horai R, Iwakura Y, Sugawara I. Protective role of interleukin-1 in mycobacterial infection in IL-1 α/β double-knockout mice. Lab Invest. 2000; 80 759-767
- 24 Adams L, Mason C, Kolls J, Scollard D, Krahenbuhl J, Nelson S. Exacerbation of acute and chronic murine tuberculosis by administration of tumor necrosis factor receptor-expressing adenovirus. J Infect Dis. 1995; 171 400-405
- 25 Kindler V, Sappino A, Grau G, Piguet P, Vassalli P. The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell. 1989; 56 731-740
- 26 Flynn J, Goldstein M, Chan J et al.. Tumor necrosis factor-α is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity. 1995; 2 561-572
- 27 Keane J, Gershon S, Wise R et al.. Tuberculosis associated with infliximab, a tumor necrosis factor (alpha)-neutralizing agent. N Engl J Med. 2001; 345 1098-1104
- 28 Kremer L, Dupre L, Wolowczuk I, Locht C. In vivo immunomodulation following intradermal injection with DNA encoding IL-18. J Immunol. 1999; 163 3226-3231
- 29 Yamada G, Shijubo N, Shigehara K, Okamura H, Kurimoto M, Abe S. Increased levels of circulating interleukin-18 in patients with advanced tuberculosis. Am J Respir Crit Care Med. 2000; 161 1786-1789
- 30 Sugawara I, Yamada H, Kaneko H, Mizuno S, Takeda K, Akira S. Role of interleukin-18 (IL-18) in mycobacterial infection in IL-18-gene-disrupted mice. Infect Immun. 1999; 67 2585-2589
- 31 Orme I, Roberts A, Griffin J, Abrams J. Cytokine secretion by CD4 T lymphocytes acquired in response to Mycobacterium tuberculosis infection. J Immunol. 1993; 151 518-525
- 32 Gong J, Zhang M, Modlin R et al.. Interleukin-10 downregulates Mycobacterium tuberculosis-induced Th1 responses and CTLA-4 expression. Infect Immun. 1996; 64 913-918
- 33 Murray P, Wang L, Onufryk C, Tepper R, Young R. T cell-derived IL-10 antagonizes macrophage function in mycobacterial infection. J Immunol. 1997; 158 315-321
- 34 Murray P, Young R. Increased antimycobacterial immunity in interleukin-10-deficient mice. Infect Immun. 1999; 67 3087-3095
- 35 Boussiotis V, Tsai E, Yunis E et al.. IL-10-producing T cells suppress immune responses in anergic tuberculosis patients. J Clin Invest. 2000; 105 1317-1325
- 36 Sugawara I, Yamada H, Mizuno S, Iwakura Y. IL-4 is required for defense against mycobacterial infection. Microbiol Immunol. 2000; 44 971-979
- 37 Adams L, Fukutomi Y, Krahenbuhl J. Regulation of murine macrophage effector functions by lipoarabinomannan from mycobacterial strains with different degrees of virulence. Infect Immun. 1993; 61 4173-4181
- 38 Luster A. Chemokines: chemotactic cytokines that mediate inflammation. N Engl J Med. 1998; 338 436-445
- 39 Sauty A, Dziejman M, Taha R et al.. The T cell-specific CXC chemokines IP-10, Mig, and I-TAC are expressed by activated human bronchial epithelial cells. J Immunol. 1999; 162 3549-3558
- 40 Sadek M, Sada E, Toossi Z, Schwander S, Rich E. Chemokines induced by infection of mononuclear phagocytes with mycobacteria and present in lung alveoli during active pulmonary tuberculosis. Am J Respir Cell Mol Biol. 1998; 19 513-521
- 41 Saukkonen J, Bazydlo B, Thomas M, Streiter R, Keane J, Kornfeld H. β-chemokines are induced by Mycobacterium tuberculosis and inhibit its growth. Infect Immun. 2002; 70 1684-1693
- 42 Qiu B, Frait K, Reich F, Komuniecki E, Chensue S. Chemokine expression dynamics in mycobacterial (type-1) and schistosomal (type-2) antigen-elicited pulmonary granuloma formation. Am J Pathol. 2001; 158 1503-1515
- 43 Rhoades E, Cooper A, Orme I. Chemokine response in mice infected with Mycobacterium tuberculosis . Infect Immun. 1995; 63 3871-3877
- 44 Lin Y, Zhang M, Barnes P. Chemokine production by a human alveolar epithelial cell line in response to Mycobacterium tuberculosis . Infect Immun. 1998; 66 1121-1126
- 45 Muller I, Cobbold S, Waldmann H, Kaufmann S. Impaired resistance to Mycobacterium tuberculosis infection after selective in vivo depletion of L3T4+ and Lyt-2+ T cells. Infect Immun. 1987; 55 2037-2041
- 46 Scanga C, Mohan V, Yu K et al.. Depletion of CD4+ T cells causes reactivation of murine persistent tuberculosis despite continued expression of interferon γ and nitric oxide synthase 2. J Exp Med. 2000; 192 347-358
- 47 Saunders B, Frank A, Orme I, Cooper A. CD4 is required for the development of a protective granulomatous response to pulmonary tuberculosis. Cell Immunol. 2002; 216 65-72
- 48 Graham N, Chaisson R. Tuberculosis and HIV infection: epidemiology, pathogenesis, and clinical aspects. Ann Allergy. 1993; 71 421-428
- 49 Cooper A, Dalton D, Stewart T, Griffin J, Russell D, Orme I. Disseminated tuberculosis in interferon γ gene-disrupted mice. J Exp Med. 1993; 178 2243-2247
- 50 Flynn J, Chan J, Triebold K, Dalton D, Stewart T, Bloom B. An essential role for interferon γ in resistance to Mycobacterium tuberculosis infection. J Exp Med. 1993; 178 2249-2254
- 51 Jouanguy E, Altare F, Lamhamedi S et al.. Interferon-γ-receptor deficiency in an infant with fatal bacille Calmette-Guérin infection. N Engl J Med. 1996; 335 1956-1961
- 52 Ottenhoff T, Kumararatne D, Casanova J. Novel human immunodeficiencies reveal the essential role of type-1 cytokines in immunity to intracellular bacteria. Immunol Today. 1998; 19 491-494
- 53 Lopez-Maderuelo D, Arnalich F, Serantes R et al.. Interferon-γ and interleukin-10 gene polymorphisms in pulmonary tuberculosis. Am J Respir Crit Care Med. 2003; 167 970-975
- 54 Giosue S, Casarini M, Alemanno L et al.. Effects of aerosolized interferon-α in patients with pulmonary tuberculosis. Am J Respir Crit Care Med. 1998; 158 1156-1162
- 55 Condos R, Rom W, Schluger N. Treatment of multidrug-resistant pulmonary tuberculosis with interferon-γ via aerosol. Lancet. 1997; 349 1513-1515
- 56 Zea A, Ochoa M, Ghosh P et al.. Changes in expression of signal transduction proteins in T lymphocytes of patients with leprosy. Infect Immun. 1998; 66 499-504
- 57 Zea A, Culotta K, Ali J et al.. Alterations in T cell signal transduction proteins in patients with tuberculosis. FASEB J. 2002; 16 A300
- 58 Serbina N, Flynn J. Early emergence of CD8+ T cells primed for the production of type 1 cytokines in the lungs of Mycobacterium tuberculosis-infected mice. Infect Immun. 1999; 67 3980-3988
- 59 Cooper A, D'Souza C, Frank A, Orme I. The course of Mycobacterium tuberculosis infection in the lungs of mice lacking expression of either perforin- or granzyme-mediated cytolytic mechanisms. Infect Immun. 1997; 65 1317-1320
- 60 Serbina N, Liu C, Scanga C, Flynn J. CD8+ CTL from lungs of Mycobacterium tuberculosis-infected mice express perforin in vivo and lyse infected macrophages. J Immunol. 2000; 165 353-363
- 61 Pinxteren L V, Cassidy J, Smedegaard B, Agger E, Andersen P. Control of latent Mycobacterium tuberculosis infection is dependent on CD8 T cells. Eur J Immunol. 2000; 30 3689-3698
- 62 Vordermeier H, Venkataprasad N, Harris D, Ivanyi J. Increase in tuberculous infection in the organs of B cell-deficient mice. Clin Exp Immunol. 1996; 106 312-316
- 63 Kaufmann S. γ/δ and other unconventional T lymphocytes: what do they see and what do they do?. Proc Natl Acad Sci USA. 1996; 93 2272-2279
- 64 D'Souza C, Cooper A, Frank A, Mazzaccaro R, Bloom B, Orme I. An anti-inflammatory role for γδ T lymphocytes in acquired immunity to Mycobacterium tuberculosis . J Immunol. 1997; 158 1217-1221
- 65 Gonzalez-Juarrero M, Turner O, Turner J, Marietta P, Brooks J, Orme I. Temporal and spatial arrangement of lymphocytes within lung granulomas induced by aerosol infection with Mycobacterium tuberculosis . Infect Immun. 2001; 69 1722-1728
- 66 Teitelbaum R, Glatman-Freedman A, Chen B et al.. A mAb recognizing a surface antigen of Mycobacterium tuberculosis enhances host survival. Proc Natl Acad Sci USA. 1998; 95 15688-15693
Carol M MasonM.D.
Division of Pulmonary/Critical Care Medicine, Louisiana State University Health Sciences Center
1901 Perdido St., Ste. 3205
New Orleans, LA 70112-1393
Email: mason@lsuhsc.edu